A detailed history of Castellan Group transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Castellan Group holds 283,679 shares of TGTX stock, worth $9.47 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares
283,679
Holding current value
$9.47 Million
% of portfolio
3.75%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$21.31 - $35.09 $6.05 Million - $9.95 Million
283,679 New
283,679 $8.54 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.85B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Castellan Group Portfolio

Follow Castellan Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castellan Group, based on Form 13F filings with the SEC.

News

Stay updated on Castellan Group with notifications on news.